Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 8, 2025Blood

Comprehensive DNA/RNA-based targeted sequencing for molecular karyotyping and clonality assessment in newly diagnosed multiple myeloma patients

View Full Paper
Ask AI
Bookmark
Share

Authors

NBNatalia BuenacheIVIria VázquezAOAlbert Oriol

Discussion

Loading...

Member takes

Overview

Assessment demonstrated improvements in chromosomal abnormalities in multiple myeloma, suggesting enhanced risk stratification.

Key Points

  • Clonality assessment revealed significant associations with survival outcomes, highlighting its prognostic relevance.
  • Next-generation sequencing demonstrated accuracy in detecting chromosomal abnormalities compared to traditional methods.
  • Molecular profiling achieved high coverage on dual platforms, enhancing diagnostic capability from limited samples.
  • Insights into gene expression clusters may guide risk-adapted treatment strategies in patients with multiple myeloma.

Cite This Study

Buenache et al. (2025) studied this question.

synapsesocial.com/papers/69362f514fa91c937236d987https://doi.org/10.1182/blood-2025-2562
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Replacing FISH with a comprehensive integrated approach for tumor genotyping and immune monitoring in multiple myeloma: The flagship study2025 · 1 citations
  2. 2Integrated cell-free DNA and RNA sequencing recapitulates bone marrow genomic and transcriptomic alterations in multiple myeloma2025 · 1 citations
  3. 3Targeted long-read sequencing with adaptive sampling in multiple myeloma: A pilot study toward a unified diagnostic platform2025 · 1 citations
  4. 4Comprehensive characterization of multiple myeloma genomes from bone marrow or peripheral blood with a novel clinical assay enables identification of resistance mechanisms2025
  5. 5Liquid biopsy for non-invasive molecular characterization and measurable residual disease analysis in multiple myeloma2025